Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
May 2019
Historique:
received: 08 07 2018
accepted: 26 10 2018
pubmed: 6 11 2018
medline: 14 8 2019
entrez: 3 11 2018
Statut: ppublish

Résumé

Renal dysfunction and its change pattern are associated with short- and long-term mortality. However, it remains to be investigated whether or not worsening renal function (WRF) defined by baseline renal function identified from different time points would provide prognostic implication on outcomes in acute coronary syndrome (ACS) patients. This study consists of 334 ACS patients (mean age 68 ± 11 years, 75% male) treated with emergent percutaneous coronary intervention (PCI). Estimated glomerular filtration rate (eGFR) was evaluated on baseline, during hospitalization, at discharge, and at 3-month follow-up. WRF was defined as a relative decrease of eGFR > 20% at 3 months using baseline eGFR identified from different time points. The primary end point was a composite event of major cardiovascular events (MACE), including all-cause death, ACS, and heart failure hospitalization. The associations of chronic kidney disease (CKD), acute kidney injury (AKI), and WRF with MACE were evaluated. During a mean follow-up of 3.3 ± 1.7 years, a total of 64 MACE were observed. Multivariable analysis revealed that CKD (hazard ratio 2.16; p = 0.018) and AKI (hazard ratio 1.95; p = 0.030) were independent predictors of MACE, but WRF did not remain as an independent predictor of MACE (p = 0.208). The highest risk was observed in AKI patients with CKD when stratified by the presence or absence of CKD and AKI. In ACS patients treated with emergent PCI, this study demonstrated that CKD and AKI were independent predictors of MACE, while there was no independent relationship between WRF and MACE.

Identifiants

pubmed: 30386919
doi: 10.1007/s00380-018-1291-5
pii: 10.1007/s00380-018-1291-5
doi:

Types de publication

Journal Article

Langues

eng

Pagination

735-744

Références

J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9
pubmed: 15464318
Circulation. 2012 Jan 17;125(2):271-9
pubmed: 22128223
Am J Cardiol. 2015 May 1;115(9):1174-8
pubmed: 25759106
Circ Heart Fail. 2017 Feb;10(2):
pubmed: 28209765
Int J Cardiol. 2014 Jun 1;174(1):57-63
pubmed: 24726211
Circ J. 2013;77(5):1315-25
pubmed: 23428718
Lancet. 2017 May 27;389(10084):2139-2151
pubmed: 28561005
Circ J. 2014;78(1):85-91
pubmed: 24107362
Am J Kidney Dis. 2010 Jul;56(1):32-8
pubmed: 20416999
Am Heart J. 2015 Mar;169(3):363-70
pubmed: 25728726
J Card Fail. 2007 Oct;13(8):599-608
pubmed: 17923350
J Am Coll Cardiol. 2016 Mar 15;67(10):1235-1250
pubmed: 26498666
Heart Vessels. 2018 Feb;33(2):163-169
pubmed: 28889231
Clin J Am Soc Nephrol. 2013 Feb;8(2):194-202
pubmed: 23124779
Eur Heart J. 2014 Feb;35(7):455-69
pubmed: 24164864
BMJ Open. 2015 Jan 06;5(1):e006497
pubmed: 25564144
Heart Vessels. 2018 Oct;33(10):1204-1213
pubmed: 29687159
Can J Cardiol. 2015 Oct;31(10):1240-4
pubmed: 26163472
Am J Cardiol. 2014 May 15;113(10):1647-51
pubmed: 24656479
Am J Cardiol. 2004 Aug 1;94(3):300-5
pubmed: 15276092
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
Circ Heart Fail. 2011 Nov;4(6):685-91
pubmed: 21903907
Lancet. 2015 Oct 10;386(10002):1465-71
pubmed: 26466051
JAMA Cardiol. 2016 Jul 1;1(4):451-60
pubmed: 27438322
Circulation. 2012 Jun 26;125(25):3099-107
pubmed: 22592896
Heart. 2015 Nov;101(22):1778-85
pubmed: 26243789
Circ Cardiovasc Interv. 2015 Aug;8(8):e002475
pubmed: 26198286
Heart Vessels. 2012 Sep;27(5):460-7
pubmed: 21822708
N Engl J Med. 2004 Sep 23;351(13):1285-95
pubmed: 15385655
J Am Soc Nephrol. 2016 Apr;27(4):1190-200
pubmed: 26264853
J Am Soc Nephrol. 2010 Feb;21(2):345-52
pubmed: 20019168
Circulation. 2011 May 10;123(18):2022-60
pubmed: 21444889
Heart Vessels. 2013 Jan;28(1):19-26
pubmed: 22160439
JAMA. 2014 Jun 25;311(24):2518-2531
pubmed: 24892770
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715

Auteurs

Kenichiro Otsuka (K)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan. otsuka_k@outlook.com.

Kenei Shimada (K)

Department of Cardiovascular Medicine, Kashiba-Seiki Hospital, Kashiba, Japan.

Hisashi Katayama (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Haruo Nakamura (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Hirotoshi Ishikawa (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Hisateru Takeda (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Kohei Fujimoto (K)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Noriaki Kasayuki (N)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28 Yayoi, Higashi-Osaka, 550-0022, Japan.

Minoru Yoshiyama (M)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH